Current Income Tax Expense (Benefit) of IMMUCELL CORP /DE/ from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
IMMUCELL CORP /DE/ annual and quarterly Current Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • IMMUCELL CORP /DE/ Current Income Tax Expense (Benefit) for the quarter ending 30 Jun 2023 was $1,525, a 33% increase year-over-year.
  • IMMUCELL CORP /DE/ Current Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2023 was $8,426, a 26% decline year-over-year.
  • IMMUCELL CORP /DE/ annual Current Income Tax Expense (Benefit) for 2024 was $10,056, a 117% increase from 2023.
  • IMMUCELL CORP /DE/ annual Current Income Tax Expense (Benefit) for 2023 was $4,627, a 40% decline from 2022.
  • IMMUCELL CORP /DE/ annual Current Income Tax Expense (Benefit) for 2022 was $7,672, a 16% decline from 2021.
Source SEC data
View on sec.gov
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Change (%)
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Change (%)

IMMUCELL CORP /DE/ Annual Current Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,056 +$5,429 +117% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $4,627 -$3,045 -40% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $7,672 -$1,493 -16% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $9,165 +$4,669 +104% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $4,496 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2017 $14,476 +$891 +6.6% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2018 2017 FY
2016 $13,585 +$10,435 +331% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
2015 $3,150 +$2,898 +1150% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $252 -$49 -16% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $301 -$407 -57% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
2012 $708 +$198 +39% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 $510 +$366 +254% 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2014 2013 FY
2010 $144 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2013 2012 FY

IMMUCELL CORP /DE/ Quarterly Current Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $8,426 $1,525 +$377 +33% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $8,049 $1,525 +$377 +33% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $7,672 $1,509 +$387 +34% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $7,285 $3,867 -$4,176 -52% 01 Jul 2022 30 Sep 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 $11,461 $1,148 +$1,148 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $10,313 $1,148 +$1,148 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $9,165 $1,122 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $8,043 +$8,043 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 $0 $0 01 Apr 2021 30 Jun 2021 10-Q/A 21 Nov 2022 2022 Q2
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-Q/A 21 Nov 2022 2022 Q1
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.